Sei Investments CO Akebia Therapeutics, Inc. Transaction History

Sei Investments CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$2.92 - $5.06 $41,554 - $72,008	-14,231 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$2.22 - $3.78 $3,119 - $5,310	-1,405 Reduced 8.99%	14,231 $37,000
Q3 2020 Nov 06, 2020	SELL	$2.39 - $13.08 $81,690 - $447,074	-34,180 Reduced 68.61%	15,636 $38,000
Q2 2020 Aug 17, 2020	BUY	$6.67 - $13.58 $22,557 - $45,927	3,382 Added 7.28%	49,816 $675,000
Q2 2020 Aug 11, 2020	BUY	$6.67 - $13.58 $222,411 - $452,825	33,345 Added 254.76%	46,434 $537,000
Q1 2020 May 14, 2020	SELL	$4.1 - $10.24 $237 - $593	-58 Reduced 0.44%	13,089 $97,000
Q4 2019 Feb 06, 2020	BUY	$3.16 - $6.73 $4,041 - $8,607	1,279 Added 10.78%	13,147 $81,000
Q3 2019 Nov 12, 2019	BUY	$3.55 - $5.4 $42,131 - $64,087	11,868 New	11,868 $45,000
Q2 2019 Aug 14, 2019	SELL	$4.1 - $8.05 $35,510 - $69,721	-8,661 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.41 - $8.73 $157,225 - $253,711	-29,062 Reduced 77.04%	8,661 $67,000
Q4 2018 Feb 13, 2019	BUY	$5.39 - $9.15 $203,326 - $345,165	37,723 New	37,723 $206,000
Q2 2018 Aug 03, 2018	SELL	$9.15 - $11.34 $14,731 - $18,257	-1,610 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$9.53 - $15.68 $5,193 - $8,545	545 Added 51.17%	1,610 $15,000
Q4 2017 Feb 08, 2018	BUY	$14.24 - $19.59 $7,390 - $10,167	519 Added 95.05%	1,065 $16,000
Q3 2017 Nov 06, 2017	BUY	$13.06 - $19.67 $7,130 - $10,739	546	546 $11,000

110

55.3M

554K

246K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $245M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.